Trial Profile
Study to evaluate the effect of global hub connectivity of the left frontal cortex (gLFC-connectivity) on entorhinal tau PET levels using [18F]AV-1451 in patients with Mild cognitive impairment and Cognitively normal elderly adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Mild cognitive impairment
- Focus Diagnostic use
- 03 Oct 2018 New trial record